Nanowire

• The scientists genetically altered the embryos to remove their ability to grow a kidney, then injected them with human stem cells.
• The embryos were then implanted into a sow and allowed to develop for up to 28 days.
• The resulting embryos were made up mostly of pig cells (although some human cells were found throughout their bodies, including in the brain).
• Such animals could be used for medical research or to grow organs for transplant, which could save many human lives.

Chimeras are only one challenge among many

• In June, scientists created “synthetic embryos” – lab-grown embryo models that closely resemble normal human embryos.
• Despite the similarities, they fell outside the scope of legal definitions of a human embryo in the United Kingdom (where the study took place).
• Like human–pig chimeras, synthetic embryos straddle two distinct categories: in this case, stem cell model and human embryo.
• In the past decade, we have also seen the development of increasingly sophisticated human cerebral organoids (or “lab-grown mini-brains”).

A new moral framework

• The confusion sparked by chimeras, embryo models, and in vitro brains shows these underlying categories no longer make sense.
• Read more:
  As scientists move closer to making part human, part animal organisms, what are the concerns?
• Should we count the proportion of human cells to determine whether a chimera counts as an animal or a human?

Moral status

• For example, utilitarian philosophers see moral status as a matter of whether a creature has any interests (in which case it has moral status), and how strong those interests are (stronger interests matter more than weaker ones).
• On this view, so long as an embryo model or brain organoid lacks consciousness, it will lack moral status.
• There are other accounts of moral status, and other ways of applying them to the entities stem cell scientists are creating.

• Currently, most electric vehicles are either too expensive for the broad mass of customers or their range is too prohibitive.
• The reasons for this are the limited energy density and the high cost of batteries.
• Leveraging its extensive 40+ years of CVD experience, CVD Equipment Corporation designs and manufactures CVD and CVI (chemical vapor infiltration) systems to advance the state of the art in nanotechnology materials.
• This order expands our installed base into Europe of our production systems for lithium-ion battery nanomaterials.” said Emmanuel Lakios, President and CEO of CVD Equipment Corporation.

• By product type, the fixed or mounted type desiccant dehumidifiers are projected to hold the largest share of the desiccant dehumidifier market during the forecast period.
• These portable desiccant dehumidifiers are increasingly being adopted in gyms, basements, sports arenas, and commercial spaces where low-capacity desiccant dehumidifiers are required.
• Factors like rising investments in product innovation for portable desiccant dehumidifiers also enable the segment's high growth rate in the desiccant dehumidifier market.
• The North American region is expected to hold the largest share of the desiccant dehumidifier market during the forecast period.

• CVD Equipment Corporation (NASDAQ: CVV ), a leading provider of chemical vapor deposition and thermal process equipment, today announced the sale of its subsidiary, Tantaline CVD ApS (Tantaline) located in Denmark.
• The Company expects to record a loss on the sale of approximately $250,000 during the quarter ending June 30, 2023.
• The revenues and net income of Tantaline for the three months ended March 31, 2023 were $0.4 million and $0.1 million, respectively.
• In 2021, CVD Equipment initiated a strategic assessment of its business, specifically evaluating the growth and profitability of each of the Company’s product lines, that included Tantaline which provides corrosion resistant surface treatments.